×
Hero Background

Ebstein’s Anomaly Companies

ID: MRFR/MED/4178-HCR
105 Pages
Rahul Gotadki
October 2025

Ebstein's anomaly is a rare congenital heart defect that primarily affects the tricuspid valve, which separates the right atrium from the right ventricle. Companies involved in the healthcare and medical device industries may play a role in the development of treatments, devices, or therapies for individuals with Ebstein's anomaly.

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Top Industry Leaders in the Ebstein’s Anomaly Market

Ebstein’s Anomaly Companies

 


Latest Ebstein’s Anomaly Companies Update:

Mayo Clinic Established a multidisciplinary Ebstein's Anomaly Clinic to provide comprehensive care and support for patients.


American Heart Association (AHA) Launched an awareness campaign on congenital heart defects in September 2023, including information on Ebstein's Anomaly.


Mended Hearts Supports adults with congenital heart defects, including Ebstein's Anomaly, through patient education and advocacy programs.


List of Ebstein’s Anomaly Key companies in the market

  • Abbott Vascular

  • Boston Scientific Corporation

  • Cordis Corporation

  • Edwards Lifesciences

  • Ge Healthcare

  • Gore Medical

  • Medtronic, Inc.

  • Numed, Inc.

  • Siemens Healthcare

  • St. Jude Medical

  • Toshiba Corporation